Nephrotoxicity pp 207-216 | Cite as

Possible Role of the Renin-Angiotensin System in the Development of Gentamicin Nephrotoxicity in the Rat

  • J. P. Morin
  • N. Thomas
  • H. Toutain
  • H. Borghi
  • J. P. Fillastre


The possible involvement of the renin angiotensin system in the development of drug induced renal failure was investigated by inhibiting the activity of Angiotensin Converting Enzyme (ACE) with Perindopril, a new specific and potent inhibitor of ACE (1). The anti-hypertensive activity of Perindopril is similar to that of Ramipril and greater than that of Enalapril (2). The pattern of gentamicin induced kidney damage is now well established (3,4) and thus allowed the use this drug to produce a model of drug induced renal failure with proximal tubule injury. This study was performed in Wistar rats and consisted of the evaluation of renal morphological, biochemical and functional parameters.


Toxicity Filtration Cage Creatinine Bacillus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    LAUBIE M., SCHIAVI P., VINCENT M., SCHMITT H. J. Cardiovasc. Pharmacol. 1984:8, 1076.Google Scholar
  2. 2.
    UNGER T., MOURSI M., GANTEN D., HERMAN K., LANG R.E. J. Cardiovasc. Pharmacol. 1986:8, 276.PubMedCrossRefGoogle Scholar
  3. 3.
    MORIN J.P., VIOTTE G., VANDEWALLE A., VAN HOOF F., TULKENS P., FILLASTRE J.P. Kidney Int. 1980:18, 583.PubMedCrossRefGoogle Scholar
  4. 4.
    BENNETT W.M. Nephron 1983:35, 73.PubMedCrossRefGoogle Scholar
  5. 5.
    CUSHMAN D.W., CHEUNG H.S. Biochem. Pharmacol. 1971:20, 1637PubMedCrossRefGoogle Scholar
  6. 6.
    GAL A.E, BRADY R.O., HIBBERT S.R., PENTCHEV P.G. New Engl. J. Med. 1975:293, 632.PubMedCrossRefGoogle Scholar
  7. 7.
    BRUNNER H.R., WAEBER B., NUSSBERGER J. Kidney Int. 1987:31 (S20), S104.Google Scholar
  8. 8.
    HIGA E.M.S., SCHOR N., BOIM M.A., ATZEN H., RAMOS O.L. Braz. J. Med. Biol. Res. 1971:18, 355Google Scholar
  9. 9.
    TERRAGNO N.A., TERRAGNO D.A., McGIFF J.C. Circ. Res. 1977: 40, 590.PubMedCrossRefGoogle Scholar
  10. 10.
    HAYLOR J., LOTE C.J. J. Physiol. 1980:298, 371.PubMedGoogle Scholar
  11. 11.
    SCHOR N., ICHIKAWA I., RENNKE H.G., TROY J.L. Kidney Int. 1981:19, 288.PubMedCrossRefGoogle Scholar
  12. 12.
    KLOTMAN P.E., BOATMAN J.E., VOLPP B.D., BAKER J.D., YARGER W.E. Kidney Int. 1985:28,118.PubMedCrossRefGoogle Scholar
  13. 13.
    LUFT F.C., ARONOFF G.R., EVAN A.P., CONNORS B.A., WEINBERGER M.H., KLEIT S.A. J. Pharmacol. Exp. Ther. 1982:220, 433.PubMedGoogle Scholar
  14. 14.
    KIMBROUGH H.M., VAUGHAN E.D., CAREY R.M., AYERS K.W., Circ. Res. 1977:40, 174.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • J. P. Morin
    • 1
  • N. Thomas
    • 1
  • H. Toutain
    • 1
  • H. Borghi
    • 1
  • J. P. Fillastre
    • 1
  1. 1.Inserm U-295Universite de RouenSaint Etienne Du RouvrayFrance

Personalised recommendations